Evidence map›Paper›PMID 25393953›Full record

ArticleACS chemical neuroscience2015

Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex.

Devon L Graham, Heather H Durai, Jamie D Garden, Evan L Cohen, Franklin D Echevarria, Gregg D Stanwood

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Dysregulation of brain dopamine systems in major depressive disorder.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Devon L GrahamDepartment of Pharmacology, ‡Vanderbilt Brain Institute, §Vanderbilt Kennedy Center, Vanderbilt University School of Medicine , Nashville, Tennessee 37232, United States.
Heather H Durai
Jamie D Garden
Evan L Cohen
Franklin D Echevarria
Gregg D Stanwood
Vanderbilt University · USJohn F. Kennedy Center for the Performing Arts · US

Funding

Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
Dopaminergic Modulation of Brain DevelopmentR01MH086629 · NIMH · VANDERBILT UNIVERSITY · PI STANWOOD, GREGG D · 2010 to 2014
$1.9M
NIGMS NIH HHS R25 GM062459NIMH NIH HHS R01MH086629
6 · The paper itself

Abstract

Disruption to dopamine homeostasis during brain development has been implicated in a variety of neuropsychiatric disorders, including depression and schizophrenia. Inappropriate expression or activity of GABAergic interneurons are common features of many of these disorders. We discovered a persistent upregulation of GAD67+ and parvalbumin+ neurons within the anterior cingulate cortex of dopamine D2 receptor knockout mice, while other GABAergic interneuron markers were unaffected. Interneuron distribution and number were not altered in the striatum or in the dopamine-poor somatosensory cortex. The changes were already present by postnatal day 14, indicating a developmental etiology. D2eGFP BAC transgenic mice demonstrated the presence of D2 receptor expression within a subset of parvalbumin-expressing cortical interneurons, suggesting the possibility of a direct cellular mechanism through which D2 receptor stimulation regulates interneuron differentiation or survival. D2 receptor knockout mice also exhibited decreased depressive-like behavior compared with wild-type controls in the tail suspension test. These data indicate that dopamine signaling modulates interneuron number and emotional behavior and that developmental D2 receptor loss or blockade could reveal a potential mechanism for the prodromal basis of neuropsychiatric disorders.

Indexed as

AnimalsCell CountDepressionEmotionsFemaleGABAergic NeuronsGlutamate DecarboxylaseGreen Fluorescent ProteinsGyrus CinguliImmunohistochemistryIn Situ Hybridization, FluorescenceInterneuronsMaleMice, Inbred C57BLMice, KnockoutMice, TransgenicDRD2 protein, mouseenhanced green fluorescent proteinGlutamate Decarboxylaseglutamate decarboxylase 1Green Fluorescent ProteinsParvalbuminsReceptors, Dopamine D2depressionDrd2-eGFPGABAInhibitoryknockoutparvalbumin

Identifiers

PMID25393953
PMCPMC4372074
OpenAlexW2043954221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.